Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Smilax sapogenin derivative and preparation and applications thereof

A technology of smilagenin and derivatives, which can be used in the field of medicine and can solve problems such as liver toxicity and gastrointestinal reactions

Inactive Publication Date: 2013-02-13
SHENYANG PHARMA UNIVERSITY +1
View PDF4 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] At present, the treatment of Alzheimer's disease in the industry is mainly based on western medicine, including cholinergic drugs, brain cell metabolism activators, cerebral blood circulation promoters, etc., but these drugs are also accompanied by hepatotoxicity and gastrointestinal reaction and other side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Smilax sapogenin derivative and preparation and applications thereof
  • Smilax sapogenin derivative and preparation and applications thereof
  • Smilax sapogenin derivative and preparation and applications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Example 1 Preparation of Epismilagenin

[0038] (1) Add smilagenin (4.16g, 10mmol), benzoic acid (2.44g, 20mmol), Ph 3 P (5.24g, 20mmol), 50ml of dry THF, DIAD (4.04g, 20mmol) dissolved in 20ml of dry THF was added dropwise with stirring at room temperature, and the reaction was completed at room temperature for 24h. After the reaction was completed, evaporate to dryness under reduced pressure, add water, stir, filter with suction, put on a silica gel column, wash away impurities with petroleum ether, and wash with petroleum ether: ethyl acetate (80:1) to obtain an intermediate product, the structure identification data is as follows:

[0039] m / z: [M+H] + =521.3620, 1 H-NMR (300MHz, CDCl 3 ): δ 8.05(2H, m, H-2',6'), 7.54 (1H, m, H-4'), 7.43 (2H, m, H-3',5'), 4.98 (1H, m , H-3), 4.42 (1H, m, H-26), 3.96 (1H, dd, J=2.52 Hz, J=11.04 Hz, H-26), 3.31 (1H, d, J=11.04 Hz H- 16), 1.08 (3H, d, J=7.11Hz, CH 3 -21), 1.00 (3H, d, J=6.72 Hz, CH 3 -27), 0.98 (3H, s,...

Embodiment 2

[0041] Example 2 Amination of the 3-position of timogenin

[0042]

[0043] (1) Add 0.8g (0.0045mol) NBS, 5ml dichloromethane (or THF) into a 50ml eggplant-shaped bottle, add dropwise triphenylphosphine dissolved in 5ml dichloromethane (or THF) at room temperature under nitrogen protection, After the dropwise addition, stir at 0-30°C for 0.5h, then add 1.2g (0.003mol) of smilagenin dissolved in 10ml of dichloromethane (or THF) dropwise and stir at 10-30°C until the reaction is complete. Add saturation The brine was extracted with dichloromethane (×2), and the organic layer was concentrated under reduced pressure to obtain a solid, which was applied to a silica gel column and washed with petroleum ether: ethyl acetate 100:1-50:1 to obtain a white solid (1.1 g, yield 78 %)[M+H] + =479.25.

[0044] (2) Add 0.96g (0.002mol) of white solid, 10ml DMF (or acetonitrile, acetone, etc.) and 1.62g dimethylamine hydrochloride to a 50ml eggplant-shaped bottle, and react at reflux at 6...

Embodiment 3

[0045] Example 3 Amination of the 3-position of timogenin

[0046]

[0047] Add 0.96g A (0.002mol), 10ml DMF (or acetonitrile, acetone, etc.), 1.7g hexahydropyridine into a 50ml eggplant-shaped flask, and react at reflux at 60°C for 12h. Add water and filter with suction to obtain a white solid, silica gel column, petroleum ether: ethyl acetate (20:1) plus triethylamine to wash the product, and obtain a white solid C (0.38g, yield about 40%) [M+H] + =484.4151, 1 H-NMR (600MHz, CDCl 3 )δ4.4 0(1H,m,J=7.5Hz,J=14.7Hz,H-26),3.96(1H,dd,J=2.58Hz,10.98Hz,H-26),3.30(1H,d, J=10.92Hz,H-16),2.34(4H,br.s,N-2CH 2 ),2.17(1H,br.s,H-3),1.08(3H,d,J=7.08Hz,CH 3 -21),0.99(3H,d,J=6.9Hz,CH 3 -27),0.95(3H,s,CH 3 -19),0.76(3H,s,CH 3 -18).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
weightaaaaaaaaaa
Login to View More

Abstract

The invention relates to a synthetic method and medical applications of a natural medicine rhizoma anemarrhenae smilax sapogenin structure derivative for resisting senile dementia. The high-purity rhizoma anemarrhenae sapogenin is used as a prodrug, and is subjected to structural modification methods such as inversion of configuration, oxidation, ammoniation, different degrees and locations of ring opening to increase the druggability, and pharmacology proves that the rhizoma anemarrhenae sapogenin has activity resisting senile dementia. The new application of the rhizoma anemarrhenae sapogenin and derivatives thereof in preparation of the medicine for resisting senile dementia is developed through the pharmacological activity.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to smilagenin derivatives and a preparation method and application thereof, in particular to the application of smilagenin derivatives in anti-senile dementia and antidepressant drugs. Background technique [0002] Alzheimer's disease (Alzheimer's disease) is the so-called senile dementia. It is a fatal neurodegenerative disease with progressive development. The clinical manifestations are deteriorating cognitive and memory functions, progressive decline in daily life ability, and various neuropsychiatric symptoms and behavioral disturbances. [0003] It is a group of primary degenerative brain diseases of unknown etiology. Most of the onsets are in old age, the onset is insidious, the course of the disease is slow and irreversible, and the main clinical manifestation is intellectual impairment. The main pathological changes are diffuse atrophy of the cortex, widening of the sulci,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07J71/00C07J9/00C07J75/00A61K31/58A61K31/575A61P25/28
Inventor 宋少江彭缨李玲芝赵勋臣
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com